Improving detoxification outcomes from methadone maintenance treatment: the interrelationship of affective states and protracted withdrawal
- PMID: 8895110
- DOI: 10.1080/02791072.1996.10472486
Improving detoxification outcomes from methadone maintenance treatment: the interrelationship of affective states and protracted withdrawal
Abstract
Changing paradigms of health care and increasing knowledge of opioid addiction continue to influence the attitudes of the health profession toward methadone maintenance treatment (MMT). This approach has again reached the forefront of attention because of its significant role in reducing HIV transmission associated with intravenous drug use. In spite of the well-documented benefits of MMT, patients continue to detoxify from methadone for a variety of reasons both overt and covert. Variable outcomes and generally poor long-term abstinence rates results. At present uncertainty still exists surrounding who should attempt detoxification, when or how this should be done, or whether in fact detoxification should be attempted at all. This article describes and examines factors that are positively and negatively associated with detoxification outcome. Evidence for the interrelationship of two notably significant determinants, affective states and protracted withdrawal, are presented and discussed as they relate to theories of relapse and outcome.
Similar articles
-
Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.Pharmacol Biochem Behav. 2007 May;87(1):141-5. doi: 10.1016/j.pbb.2007.04.010. Epub 2007 Apr 21. Pharmacol Biochem Behav. 2007. PMID: 17532034
-
Heroin craving and drug use in opioid-maintained volunteers: effects of methadone dose variations.Exp Clin Psychopharmacol. 2002 Feb;10(1):39-46. doi: 10.1037//1064-1297.10.1.39. Exp Clin Psychopharmacol. 2002. PMID: 11866251 Clinical Trial.
-
PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.Eur J Pharmacol. 2008 Jan 28;579(1-3):160-6. doi: 10.1016/j.ejphar.2007.09.042. Epub 2007 Oct 10. Eur J Pharmacol. 2008. PMID: 17977528 Clinical Trial.
-
Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment.J Addict Dis. 1999;18(2):5-21. doi: 10.1300/J069v18n02_02. J Addict Dis. 1999. PMID: 10334372 Review.
-
Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored.Mt Sinai J Med. 2001 Jan;68(1):62-74. Mt Sinai J Med. 2001. PMID: 11135508 Review.
Cited by
-
Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder.JAMA Netw Open. 2021 Aug 2;4(8):e2119600. doi: 10.1001/jamanetworkopen.2021.19600. JAMA Netw Open. 2021. PMID: 34351402 Free PMC article.
-
A stage I pilot study of acceptance and commitment therapy for methadone detoxification.Drug Alcohol Depend. 2012 Oct 1;125(3):215-22. doi: 10.1016/j.drugalcdep.2012.02.015. Epub 2012 Mar 15. Drug Alcohol Depend. 2012. PMID: 22425411 Free PMC article. Clinical Trial.
-
Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper.JAMA Netw Open. 2022 Sep 1;5(9):e2234168. doi: 10.1001/jamanetworkopen.2022.34168. JAMA Netw Open. 2022. PMID: 36173629 Free PMC article.
-
The Need for Psychosocial Interventions to Facilitate the Transition to Extended-Release Naltrexone (XR-NTX) Treatment for Opioid Dependence: A Concise Review of the Literature.Subst Abuse. 2016 Aug 4;10:65-8. doi: 10.4137/SART.S39067. eCollection 2016. Subst Abuse. 2016. PMID: 27512336 Free PMC article. Review.
-
Using Acceptance and Commitment Therapy during Methadone Dose Reduction: Rationale, Treatment Description, and a Case Report.Cogn Behav Pract. 2009 May 1;16(2):205-213. doi: 10.1016/j.cbpra.2008.08.003. Cogn Behav Pract. 2009. PMID: 20628479 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical